Crystal structure of a vitamin D 3 analog, ZK203278, showing dissociated profile

Anticancer Research

Volumn 32, Issue 1 PART 2, 2012, Pages 335-339

  Rochel, Natacha ^a   Moras, Dino ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

1 ,25(OH) 2D 3; Crystal structure; Vitamin D nuclear receptor; ZK203278

Indexed keywords

CALCITRIOL DERIVATIVE; COLECALCIFEROL DERIVATIVE; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG; ZK 203278;

CONFERENCE PAPER; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISSOCIATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

CRYSTALLOGRAPHY, X-RAY; HISTIDINE; HUMANS; LIGANDS; MODELS, CHEMICAL; RECEPTORS, CALCITRIOL; THIAZOLES; VITAMIN D;

EID: 84856015409     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. DeLuca HF: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 50(6): 1689S-1696S, 2004.
2. Hendy GN, Hruska KA, Mathew S and Goltzman D: New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int 69: 218-223, 2006. (Pubitemid 43323070)
3. Christakos S, Dhawan P, Benn P, Porta A, Hediger M, Oh GT, Jeung EB, Zhong Y, Ajibade D, Dhawan K and Joshi J: Vitamin D: Molecular mechanism of action. Ann NY Acad Sci 1116: 340-348, 2007.
4. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C and Demay M: Vitamin D and human health: lessons from vitamin D receptor-null mice. J Steroid Biochem Mol Biol 29: 726-776, 2008.
5. Vieth R: Vitamin D toxicity, policy, and science. J Bone Min Res 22: V64-V68, 2007.
6. 3 as pluripotent immunomodulators. J Cell Biochem 88: 223-226, 2003.
7. Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M and Allegretto EA: Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem Biol 6: 265-275, 1999. (Pubitemid 29363177)
8. Daniel C, Schlauch T, Zügel U, Steinmeyer A, Radeke HH, Steinhilber D and Stein J: 22-Ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities. Eur J Clin Invest 35: 343-349, 2005. (Pubitemid 40691282)
9. Ma Y, Khalifa B, Yee YK, Lu J, Memezawa A, Savkur RS, Yamamoto Y, Chintalacharuvu SR, Yamaoka K, Stayrook KR, Bramlett KS, Zeng QQ, Chandrasekhar S, Yu XP, Linebarger JH, Iturria SJ, Burris TP, Kato S, Chin WW and Nagpal S: Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest 116: 892-904, 2006.
10. Amuchastegui S, Danie KCl and Adorini L: Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist. Transplantation 80: 81-87, 2005. (Pubitemid 40980899)
11. Stein MS and Wark DL: An update on the therapeutic potential of vitamin D analogs. Expert. Opin Invest Drugs 12: 825-840, 2003. (Pubitemid 36622190)
12. Eelen G, Gysemans C, Verlinden L, Vanoirbeek E, DeClercq P, Van Haver D, Mathieu C, Bouillon R and Verstuyf A: Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr Med Chem 14: 1893-1910, 2007. (Pubitemid 47163407)
13. Zügel U, Steinmeyer A, May E, Lehmann M and Asadullah K: Immunomodulation by a novel, dissociated vitamin D analogue. Exp Dermatol 18: 619-627, 2009.
14. Rochel N, Wurtz JM, Mitschler A, Klaholz B and Moras D: The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5: 173-179, 2000. (Pubitemid 30105446)
15. Rochel N and Moras D: Ligand binding domain of vitamin D receptors. Cur Top Med Chem 6: 1229-1241, 2006. (Pubitemid 44110912)
16. Hourai S, Rodrigues LC, Antony P, Reina-San Martin B, Ciesielski F, Magnier BC, Schoonjans K, Mourino A, Rochel N and Moras D: Structure-based design of a superagonist ligand for the vitamin D nuclear receptors. Chem Biol 15: 383-392, 2008. (Pubitemid 351508435)
17. Rochel N, Tocchini-Valentini G, Egea PF, Juntunen K, Garnier JM, Vihko P and Moras D: Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. Eur J Biochem 268: 971-979, 2001. (Pubitemid 32328341)
18. Otwinowski Z and Minor W: Processing of X-ray data collected in oscillation mode. Met Enzymol 276: 307-326, 1997. (Pubitemid 27085611)
19. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T and Warren GL: Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54: 905-921, 1998.
20. Jones TA, Zou JY, Cowan SW and Kjeldgaard M: Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47: 110-119, 1991.
21. Tocchini-Valentini G, Rochel N, Wurtz JM and Moras D: Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogs calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification. J Med Chem 47: 1956-1961, 2004. (Pubitemid 38453914)
22. Eelen G, Verlinden L, Rochel N, Ciaessens F, De Clercq P, Vandewalle M, Tocchini-Valentini G, Moras D, Bouillon R and Verstuyf A: Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol Pharmacol 67: 1566-1573, 2005. (Pubitemid 40594155)